Attention Getter: Shire Looks To Vyvanse With Adderall XR Generics In Full Force
This article was originally published in The Pink Sheet Daily
Executive Summary
The drug maker awaits labeling decision from the FDA for its ADHD candidate Intuniv after receiving a "complete response" letter.